Fasting Study of Metolazone Tablets 10 mg and Zaroloxyn® Tablets 10 mg
Clinical trial NCT00650195 · COMPLETED
Trial details
- NCT number
- NCT00650195
- Sponsor
- Mylan Pharmaceuticals Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-02-01
- Primary completion
- 2004-02-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.